Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$66.39
-0.74-1.1%
Last update: Oct 16, 4:39 PM
$66.35
-0.78-1.16%
BridgeBio Pharma Inc (BBIO) Stock Price, Quote, News & History
BBIONASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.
Other companies in BridgeBio Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
BridgeBio Pharma has a consensus price target of $94.14.
The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $66.35 last updated October 16, 2026 at 4:39 PM EDT.
There are no upcoming dividends for BridgeBio Pharma.
BridgeBio Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for BridgeBio Pharma.
BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
